The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axelrod, R., & Hamilton, W. D. (1981) · Science · doi:10.1126/science.7466396 · Cited by 20,065
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Marwaha, S., & Johnson, S. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0762-4 · Cited by 922
Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
Bilder, R. M., Goldman, R. S., Robinson, D., Reiter, G., Bell, L., Bates, J. A., Pappadopulos, E., Willson, D. F., Alvir, J. M. J., Woerner, M. G., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.549 · Cited by 906
One hundred years of schizophrenia: a meta-analysis of the outcome literature
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 762
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 620
Developmental Processes in Schizophrenic Disorders: Longitudinal Studies of Vulnerability and Stress
Nuechterlein, K. H., Dawson, M. E., Gitlin, M., Ventura, J., Goldstein, M. J., Snyder, K. S., Yee, C. M., & Mintz, J. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.3.387 · Cited by 468
The functional significance of symptomatology and cognitive function in schizophrenia
Velligan, D. I., Mahurin, R. K., Diamond, P. L., Hazleton, B. C., Eckert, S. L., & Miller, A. L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00010-8 · Cited by 345
Harvey, P. D., Howanitz, E., Parrella, M., White, L., Davidson, M., Mohs, R. C., Hoblyn, J., & Davis, K. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1080 · Cited by 338
Cited by
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
Self-citationLongitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422
The Functional Significance of Social Cognition in Schizophrenia: A Review
Couture, S. M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl029 · Cited by 1,276
Bowie, C. R., Reichenberg, A., Patterson, T. L., Heaton, R. K., & Harvey, P. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.418 · Cited by 763
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., Keefe, R. S. E., Mesholam-Gately, R., Mintz, J., Seidman, L. J., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010043 · Cited by 744
Self-citationCognitive deficits and functional outcome in schizophrenia
Bowie, C. R., & Harvey, P. D. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.531 · Cited by 647
Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior
Morris, S. E., & Cuthbert, B. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.1/smorris · Cited by 638
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.06091591 · Cited by 560
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The Social Cognition Psychometric Evaluation Study: Results of the Expert Survey and RAND Panel
Pinkham, A. E., Penn, D. L., Green, M. F., Buck, B., Healey, K., & Harvey, P. D. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt081 · Cited by 504
Calhoun, V. D., & Sui, J. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.12.005 · Cited by 461
Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia
Lencz, T., Smith, C. W., McLaughlin, D., Auther, A., Nakayama, E., Hovey, L., & Cornblatt, B. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.005 · Cited by 402
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Neurocognitive predictors of work outcome in recent-onset schizophrenia.
Nuechterlein, K. H., Subotnik, K. L., Green, M. F., Ventura, J., Asarnow, R. F., Gitlin, M. J., Yee, C. M., Gretchen-Doorly, D., & Mintz, J. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr084 · Cited by 297
Affective traits in schizophrenia and schizotypy
Horan, W. P., Blanchard, J. J., Clark, L. A., & Green, M. F. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn083 · Cited by 290
Subramaniam, K., Luks, T. L., Fisher, M., Simpson, G. V., Nagarajan, S., & Vinogradov, S. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.024 · Cited by 289
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
The MATRICS initiative: developing a consensus cognitive battery for clinical trials
Green, M. F., & Nuechterlein, K. H. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.006 · Cited by 284
Carter, C. S., & Barch, D. M. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm081 · Cited by 274
Neurocognition: Clinical and Functional Outcomes in Schizophrenia
Lepage, M., Bodnar, M., & Bowie, C. R. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900103 · Cited by 266
Integrated Psychological Therapy (IPT) for Schizophrenia: Is It Effective?
Roder, V. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl021 · Cited by 265
Ho, B.-C., Milev, P., O’Leary, D. S., Librant, A., Andreasen, N. C., & Wassink, T. H. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.731 · Cited by 265
Cognition in schizophrenia: Past, present, and future
Green, M. F., & Harvey, P. D. (2014) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2014.02.001 · Cited by 258
Kern, R. S., Gold, J. M., Dickinson, D., Green, M. F., Nuechterlein, K. H., Baade, L. E., Keefe, R. S. E., Mesholam-Gately, R. I., Seidman, L. J., Lee, C., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.008 · Cited by 251
Social Cognition in Schizophrenia
Green, M. F., & Leitman, D. I. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn045 · Cited by 214
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Arneric, S. P., Holladay, M., & Williams, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.033 · Cited by 208
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Geyer, M. A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033358 · Cited by 159
Green, M. F., Schooler, N. R., Kern, R. S., Frese, F. J., Granberry, W., Harvey, P. D., Karson, C. N., Peters, N., Stewart, M., Seidman, L. J., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030414 · Cited by 159
Cognitive impairments in psychotic disorders: common mechanisms and measurement
Barch, D. M., & Sheffield, J. M. (2014) · World Psychiatry · doi:10.1002/wps.20145 · Cited by 154
Social Cognition in Schizophrenia
Green, M. F., & Horan, W. P. (2010) · Current Directions in Psychological Science · doi:10.1177/0963721410377600 · Cited by 145
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110
The future of supported employment for people with severe mental illness
Drake, R. E., & Bond, G. R. (2008) · Psychiatric Rehabilitation Journal · doi:10.2975/31.4.2008.367.376 · Cited by 95
Cognitive dysfunction in major depression: From assessment to novel therapies
Atique-Ur-Rehman, H., & Neill, J. C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.013 · Cited by 72
Obsessive-compulsive symptoms in schizophrenia: an up-to-date review of literature
Tezenas du Montcel, C., Pelissolo, A., Schürhoff, F., & Pignon, B. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1051-y · Cited by 61
Zhou, Y., Rosenheck, R., Mohamed, S., Zhang, J., Chang, Q., Ou, Y., Sun, B., Ning, Y., & He, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.009 · Cited by 47
“…Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery (MCCB), which has been accepted as a standard measure of cognitive functioning by the U.S. Food and Drug Administration for use in clinical trials of medications intended to improve neurocognition (Marder and Fenton, 2004).”
BackgroundMethodHiguchi, Y., Sumiyoshi, T., Seo, T., Suga, M., Takahashi, T., Nishiyama, S., Komori, Y., Kasai, K., & Suzuki, M. (2017) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2017.01.001 · Cited by 42
Eack, S. M., Newhill, C. E., & Keshavan, M. S. (2016) · Journal of the Society for Social Work and Research · doi:10.1086/686538 · Cited by 37
“The importance of treating cognitive impairments in those with schizophrenia has led to several initiatives to support the development of cognitive enhancing interventions (Marder & Fenton, 2004; Carter & Barch, 2007).”
BackgroundAcheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26
Animal Paradigms to Assess Cognition with Translation to Humans
Wallace, T. L., Ballard, T. M., & Glavis-Bloom, C. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-16522-6_2 · Cited by 26
Neurostimulation techniques in the treatment of nicotine dependence: a review
Rachid, F. (2016) · The American Journal on Addictions · doi:10.1111/ajad.12405 · Cited by 24
Metadata
- Authors
- Marder, S. R., & Fenton, W.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 72
- Issue
- 1
- Pages
- 5-9
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2020847388
- Cited by
- 421
- References
- 24
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.